Midbrain Diameter Measurements on High-Resolution Computer Tomography Scans to aid diagnosis of Progressive Supranuclear Palsy
Objective: To establish whether high-resolution computer tomography (CT) scans can aid the diagnosis of progressive supranuclear palsy (PSP), and multiple system atrophy (MSA). Background: The…Burden of progressive supranuclear palsy: A systematic literature review
Objective: The objective of this research was to identify available data on burden of progressive supranuclear palsy (PSP), a 4-repeat tauopathy. Research questions focused on…Accuracy of the International Parkinson Disease and Movement Disorder Society Progressive Supranuclear Palsy Diagnostic Criteria (IPD-MDS-PSP)
Objective: To evaluate the accuracy of the IPD-MDS-PSP criteria to differentiate PSP-Richardson (PSP-R) from PSP-parkinsonism (PSP-P), the most common PSP phenotypes. Background: The new International…The clinical spectrum of motor stereotypies in progressive supranuclear palsy: An early, frequent and underestimated symptom
Objective: To describe the frequency, phenomenology, and clinical and neuropsychological correlates of stereotypies in PSP. Background: Stereotypies are repetitive, patterned and predictable purposeless movements. Unlike…Comparative study of non-motor symptoms in patients with progressive supranuclear palsy and age, gender, duration of illness matched patients with Parkinson’s disease
Objective: To assess the frequency of NMS in PSP and compare them to age, gender and duration of illness matched PD patients. Background: Non-motor symptoms…Methylphenidate in Progressive Supranuclear Palsy [PSP] – Old drug, New Indications?
Objective: To evaluate whether Methylphenidate can improve some symptoms of PSP. Background: PSP is a neurodegenerative disorder with limited therapeutic options. Methylphenidate[MPH] , a drug…Role of uric acid as a prognostic biomarker in Idiopathic Parkinson’s disease and Parkinson Plus Syndrome
Objective: To estimate the levels of serum uric acid in Idiopathic Parkinson’s disease (IPD) and various Parkinson plus syndromes (PPS). To correlate the uric acid…Clinical features and natural history of pathologically-confirmed corticobasal degeneration: A Japanese validation study of CBD (J-VAC study)
Objective: To elucidate the clinical features and natural history of CBD. Background: Recently, various clinical phenotypes of corticobasal degeneration (CBD) have been reported; on the…Vascular parkinsonism: Clinical features and comparison with Parkinson’s disease
Objective: To define the clinical features of vascular parkinsonism (VP) and compare it to idiopathic Parkinson’s disease (iPD). Background: The main differential diagnosis of VP…Diagnostic Impact of Movement Disorders Subspecialty Consultations at a VA Hospital
Objective: Review the impact of subspecialty care on diagnosis patterns of patients with parkinsonism at the Jesse Brown VA (JBVA), a VA Consortium center. Background:…
- « Previous Page
- 1
- …
- 35
- 36
- 37
- 38
- 39
- …
- 49
- Next Page »